2015
DOI: 10.1097/iop.0000000000000260
|View full text |Cite
|
Sign up to set email alerts
|

Orbital Fat Decompression for Thyroid Eye Disease

Abstract: While orbital fat decompression can and, at times, should be combined with bone decompression to treat proptosis resulting from thyroid eye disease, orbital fat decompression alone is associated with lower rates of surgical morbidity, and is especially effective for group I and II patients, those with greater preoperative proptosis, and those with a history of radiation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0
6

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(11 citation statements)
references
References 9 publications
0
5
0
6
Order By: Relevance
“… 16 18 Removal of orbital fat results in an exophthalmos reduction of approximately 3–4 mm. 19 22 In some cases, the average exophthalmos reduction following the fat decompression is 5.3 mm. 23 Exophthalmos regression as a result of endonasal endoscopic orbital decompression via the transethmoidal approach is 3.5–6 mm.…”
Section: Discussionmentioning
confidence: 99%
“… 16 18 Removal of orbital fat results in an exophthalmos reduction of approximately 3–4 mm. 19 22 In some cases, the average exophthalmos reduction following the fat decompression is 5.3 mm. 23 Exophthalmos regression as a result of endonasal endoscopic orbital decompression via the transethmoidal approach is 3.5–6 mm.…”
Section: Discussionmentioning
confidence: 99%
“…Based on these findings, a decrease in orbital fat is needed to alleviate exophthalmos. Other studies have revealed the effectiveness of surgery (eg, orbital fat decompression) to accomplish this difference 17,18. Richter et al17 reported the effectiveness of transpalpebral decompression.…”
Section: Discussionmentioning
confidence: 99%
“…Another study also showed that exophthalmos values did not significantly improve after methylprednisolone pulse therapy 16. Therefore, decreasing the amount of orbital fat appears to be the most important factor in alleviating exophthalmos, and studies have shown that orbital fat-decompression surgery is effective for exophthalmos due to TAO 17,18. Another study showed that intravenous administration of teprotumumab, a human monoclonal antibody inhibitor of IGF1R, was effective for exophthalmos in patients with active TAO 19.…”
Section: Introductionmentioning
confidence: 99%
“…Осложнения внутренней декомпрессии орбиты разделяют на интраоперационные и послеоперационные [14,19].…”
Section: внутренняя декомпрессия орбитыunclassified